Nordicus Partners Corporation (NORD)
| Market Cap | 33.86M |
| Revenue (ttm) | 5.00K |
| Net Income (ttm) | -2.90M |
| Shares Out | 17.82M |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 200 |
| Average Volume | 267 |
| Open | 1.900 |
| Previous Close | 1.600 |
| Day's Range | 1.900 - 1.900 |
| 52-Week Range | 1.250 - 10.160 |
| Beta | -3.09 |
| RSI | 43.18 |
| Earnings Date | Aug 18, 2025 |
About Nordicus Partners
Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health. It also provides corporate finance activities, including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in... [Read more]
Financial Performance
In 2024, Nordicus Partners's revenue was $5,000, an increase of 100.00% compared to the previous year's $2,500. Losses were -$2.90 million, 872.9% more than in 2023.
Financial StatementsNews
Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors
Beverly Hills, California, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a business accelerator and holding company specializing in provi...
Nord Anglia Education's collaboration with IMG Academy creates exciting new opportunities for student performance, leadership, and wellbeing
LONDON , May 1, 2025 /PRNewswire/ -- Leading international schools organisation Nord Anglia Education today announced a host of new opportunities launching in summer 2025 through its sport and wellbei...
Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia
BEVERLY HILLS, California, April 03, 2025 (GLOBE NEWSWIRE) -- Bio-Convert A/S (“Bio-Convert”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial co...
Orocidin's QR-01 Shows Positive Results in Treating Periodontitis in Dogs
BEVERLY HILLS, California, April 02, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulti...
Orocidin and Syngene Partner to Accelerate Biotech Innovation
BEVERLY HILLS, California, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consultin...
Orocidin QR-01 Shows a Good Safety Profile in Preclinical Toxicity Study
BEVERLY HILLS, California, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consultin...
Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia
BEVERLY HILLS, California, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bio-Convert ApS (“Bio-Convert”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial con...
Oricidin Launches Groundbreaking Dental Gel for Long-Term Periodontitis Treatment
BEVERLY HILLS, California, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S, a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company spe...
Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin's Breakthrough Treatment for Periodontitis
BEVERLY HILLS, California, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic...
Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025
BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic a...
NORDICUS now trading under symbol NORD
BEVERLY HILLS, California, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic a...
Nordicus Partners Corporation Acquires the Remaining 5% Shares In Orocidin A/S
Beverly Hills, California., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Nordicus Partners Corporation Acquires Bio-Convert ApS
Beverly Hills, California., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Nordicus Partners Corporation Announces Reverse Stock Split
Beverly Hills, California., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Nordicus Partners To Host Investor Relations Webinar on July 10, 2024
Beverly Hills, California., July 03, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark
Beverly Hills, California., June 21, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Orocidin – New Insights Into The Treatment Of Periodontitis
Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
Beverly Hills, California, June 04, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic ...
Nordicus Partners Corporation Engages FORCE Family Office
Beverly Hills, California., May 23, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic ...
Nordicus Partners Corporation Acquires 95% Stake in Orocidin A/S
Beverly Hills, California., May 15, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic ...
Nordicus Partners Corporation Uplists to OTCQB
Beverly Hills, California., May 09, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic ...
NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK
Beverly Hills, California., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nor...
NORDICUS PARTNERS CORPORATION TAKES A SIGNIFICANT EQUITY STAKE IN MAG MILE CAPITAL, INC.
Las Vegas, Nevada., June 21, 2023 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company, specializing in providing Nordic and...
EKIMAS CORPORATION CHANGES NAME TO NORDICUS PARTNERS CORPORATION AND TICKER SYMBOL TO ‘NORD'
Las Vegas, Nevada., May 22, 2023 (GLOBE NEWSWIRE) -- EKIMAS Corporation (OTC PINK: NORD) (“EKIMAS” or the “Company”), a financial consulting company specializing in providing Nordic companies with th...